Search alternatives:
changes decrease » change increases (Expand Search), larger decrease (Expand Search), largest decrease (Expand Search)
point decrease » point increase (Expand Search)
Showing 8,761 - 8,780 results of 45,209 for search '(( significant ((amount decrease) OR (point decrease)) ) OR ( significant changes decrease ))', query time: 0.77s Refine Results
  1. 8761
    The relative changes between the enzymatic treatment groups and the control (untreated) group.

    The relative changes between the enzymatic treatment groups and the control (untreated) group. by Sakari S. Karhula (3704521)

    Published 2017
    “…After collagenase treatment, decreasing relative change in the X-ray attenuation obtained from PTA-stained AC (A) was significant in the surface and deeper layers of the tissue. …”
    Save to List
    Saved in:
  2. 8762
    Table_4_HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.xlsx

    Table_4_HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.xlsx by Zhijian Huang (1649578)

    Published 2022
    “…TMB in the HAUS5-low expression group was significantly higher than that in the high expression group. …”
    Save to List
    Saved in:
  3. 8763
    Image_1_HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.tif

    Image_1_HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.tif by Zhijian Huang (1649578)

    Published 2022
    “…TMB in the HAUS5-low expression group was significantly higher than that in the high expression group. …”
    Save to List
    Saved in:
  4. 8764
    Table_1_HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.xlsx

    Table_1_HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.xlsx by Zhijian Huang (1649578)

    Published 2022
    “…TMB in the HAUS5-low expression group was significantly higher than that in the high expression group. …”
    Save to List
    Saved in:
  5. 8765
    Table_2_HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.xlsx

    Table_2_HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.xlsx by Zhijian Huang (1649578)

    Published 2022
    “…TMB in the HAUS5-low expression group was significantly higher than that in the high expression group. …”
    Save to List
    Saved in:
  6. 8766
    Table_3_HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.xlsx

    Table_3_HAUS5 Is A Potential Prognostic Biomarker With Functional Significance in Breast Cancer.xlsx by Zhijian Huang (1649578)

    Published 2022
    “…TMB in the HAUS5-low expression group was significantly higher than that in the high expression group. …”
    Save to List
    Saved in:
  7. 8767
    Mobile phone mobility index (MPMI) values by week in Korea in 2020.

    Mobile phone mobility index (MPMI) values by week in Korea in 2020. by Ye Ji Lee (11055903)

    Published 2023
    Save to List
    Saved in:
  8. 8768
    (A) Rapid light curves, (B) maximum electron transport rates (ETR<sub>max</sub>) and (C) minimum saturating irradiances (E<sub>k</sub>) derived from the model fitted according to Platt et al.

    (A) Rapid light curves, (B) maximum electron transport rates (ETR<sub>max</sub>) and (C) minimum saturating irradiances (E<sub>k</sub>) derived from the model fitted according to P... by Malte Ostendarp (13217973)

    Published 2025
    Save to List
    Saved in:
  9. 8769
    (A) Rapid light curves, (B) maximum electron transport rates (ETR<sub>max</sub>) and (C) minimum saturating irradiances (E<sub>k</sub>) derived from the model fitted according to Platt et al.

    (A) Rapid light curves, (B) maximum electron transport rates (ETR<sub>max</sub>) and (C) minimum saturating irradiances (E<sub>k</sub>) derived from the model fitted according to P... by Malte Ostendarp (13217973)

    Published 2025
    Save to List
    Saved in:
  10. 8770
    Moving distances in the open-field.

    Moving distances in the open-field. by Wataru Matsunaga (3452621)

    Published 2023
    Save to List
    Saved in:
  11. 8771
    Overlap of differentially expressed genes (DEGs) and gene ontology (GO) analysis identifies two distinct gene expression patterns within <i>ATRX</i> aberrant neuroblastoma.

    Overlap of differentially expressed genes (DEGs) and gene ontology (GO) analysis identifies two distinct gene expression patterns within <i>ATRX</i> aberrant neuroblastoma. by Michael R. van Gerven (16764526)

    Published 2023
    Save to List
    Saved in:
  12. 8772
    Myeloid cell development is negatively affected by the addition of PCP in the 0, 24, 48, and 72 hpf treatment groups.

    Myeloid cell development is negatively affected by the addition of PCP in the 0, 24, 48, and 72 hpf treatment groups. by Aleeza Namit (12295157)

    Published 2022
    Save to List
    Saved in:
  13. 8773
    qRT-PCR indicates <i>runx1</i>, <i>cmyb</i>, and <i>cd41</i> expression is lower in PCP treated embryos.

    qRT-PCR indicates <i>runx1</i>, <i>cmyb</i>, and <i>cd41</i> expression is lower in PCP treated embryos. by Aleeza Namit (12295157)

    Published 2022
    Save to List
    Saved in:
  14. 8774
    DataSheet7_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP

    DataSheet7_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
    Save to List
    Saved in:
  15. 8775
    DataSheet6_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP

    DataSheet6_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
    Save to List
    Saved in:
  16. 8776
    DataSheet4_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP

    DataSheet4_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
    Save to List
    Saved in:
  17. 8777
    DataSheet5_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP

    DataSheet5_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
    Save to List
    Saved in:
  18. 8778
    DataSheet1_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.PDF

    DataSheet1_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.PDF by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
    Save to List
    Saved in:
  19. 8779
    DataSheet3_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP

    DataSheet3_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
    Save to List
    Saved in:
  20. 8780
    DataSheet2_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP

    DataSheet2_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP by Sabrina R. Mackinnon (12496324)

    Published 2022
    “…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
    Save to List
    Saved in:

Search Tools: